Olema Pharmaceuticals: Insider Trading Activity January 2026
ByAinvest
Wednesday, Jan 14, 2026 10:45 pm ET1min read
OLMA--
Olema Pharmaceuticals, Inc. (OLMA) recently reported that Myles David C., Chief Discovery & Non-Clinical Development Officer, executed a series of transactions. On January 12, 2026, he sold 10,000 shares at a price of $28.34 per share. The following day, he purchased 50,000 shares at $4.87 per share, and then sold 49,800 shares at $27.60 per share. Additionally, he sold 200 shares at $28.49 per share. On January 14, he again purchased 50,000 shares at $4.87 per share, and subsequently sold 14,997 shares at $28.60 per share and 35,003 shares at $28.99 per share.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet